C. Safran

发表

Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.

H. Portier, P. Chavanet, J. Kisterman, 1994, Scandinavian journal of infectious diseases.

Pharmacokinetics of cefotaxime in preterm infants.

A. Péchinot, P. Chrétien, A. Kazmierczak, 1990, Developmental pharmacology and therapeutics.

Cefotaxime Optimal Dosage in Adult Patients

Claude Carbón, A. Simon, C. Safran, 2012, Drugs.

Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.

F. Quiniou, P. Bégué, B. Quinet, 1984, Developmental pharmacology and therapeutics.

Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.

E. Mallet, P. Bégué, D. Floret, 1984, The Journal of antimicrobial chemotherapy.

Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin/clavulanic acid for treatment of acute otitis media in children.

S. Bobin, P. Géhanno, B. Barry, 1994, Scandinavian journal of infectious diseases.

Cefpodoxime proxetil: dosage, efficacy and tolerance in adults suffering from respiratory tract infections.

C. Safran, 1990, The Journal of antimicrobial chemotherapy.

Market Analysis of Vitamin Supplementation in Infants and Children: Evidence From the Dietary Supplement Label Database

C. Safran, 2015 .

Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children.

E. Bingen, M. Rangaraj, C. Safran, 1994, Diagnostic microbiology and infectious disease.

Dibekacin in the newborn: pharmacokinetics and evaluation of ototoxicity in neonates and premature infants.

F. Quiniou, P. Bégué, C. Safran, 1984, Developmental pharmacology and therapeutics.